The NIH has joined with over 15 companies and not-for-profit organizations to create the Accelerating Medicines Partnership, a public-private partnership focused on discovering new targets and biomarkers for 4 diseases. The precompetitive PPP will make results publicly available, aiming to spur innovation from all sectors of the industry.